Hypothesis\n\nWe propose that p62/SQSTM1‑dependent aggresome formation acts as a conditional sink for NLRP3‑activating danger signals (e.g., mitochondrial DNA, oxidized phospholipids) and that this sequestration suppresses inflammasome activation only when autophagic flux remains competent. When flux is blocked, persistent aggresomes exacerbate lysosomal stress and potentiate NLRP3 activation.\n\n## Mechanistic Rationale\n\n- p62 binds ubiquitinated cargo and recruits HDAC6, promoting aggresome assembly around the microtubule organizing center (p62‑HDAC6 aggresome formation).\n- Aggresomes sequester misfolded proteins into a densely packed, relatively inert state, reducing their availability to trigger cytosolic sensors.\n- However, aggresomes are still delivered to lysosomes for clearance; if autophagic flux is impaired (e.g., by lysosomal damage or genetic deficiency), the accumulated aggregates provoke lysosomal membrane permeabilization, cathepsin B release and mitochondrial ROS, which are established NLRP3 activators (lysosomal damage and NLRP3 activation, metaflammation in aging).\n- Thus, the same aggregation process can be protective or pathogenic depending on the downstream clearance capacity.\n\n## Testable Predictions\n\n1. In aged macrophages, pharmacological enhancement of HDAC6‑driven aggresome formation (e.g., via tubacin) will decrease NLRP3‑dependent IL‑1β release only when autophagy flux is stimulated (e.g., rapamycin) or genetically intact.\n2. Combining HDAC6 enhancement with autophagy inhibition (e.g., bafilomycin A1 or ATG5 knock‑down) will lead to increased ASC speck formation, cathepsin B cytosol leakage, and higher IL‑1β compared with controls.\n3. Sequestration of mitochondrial DNA into aggresomes will be detectable by immunofluorescence colocalization of p62 with mtDNA, and this colocalization will inversely correlate with NLRP3 activation under flux‑competent conditions.\n\n## Experimental Design\n\n- Cell model: Bone‑marrow‑derived macrophages from young (3 mo) and aged (24 mo) mice.\n- Treatments: (a) vehicle, (b) HDAC6 activator (tubacin 5 µM), (c) autophagy inducer (rapamycin 100 nM), (d) autophagy inhibitor (bafilomycin A1 10 nM), (e) combinations.\n- Readouts: (i) Western blot for cleaved caspase‑1 and IL‑1β in supernatant; (ii) ASC speck quantification by microscopy; (iii) Lysotracker loss and cathepsin B cytosolic puncta; (iv) MitoSOX for ROS; (v) co‑localization of p62 with mtDNA (immunofluorescence).\n- Expected outcome: Tubacin reduces IL‑1β and ASC specks only when paired with rapamycin; tubacin + bafilomycin shows a synergistic increase in inflammasome readouts.\n\n## Potential Pitfalls & Alternatives\n\n- Over‑activation of aggresome formation could sequester essential proteins, causing toxicity; monitor total proteasome activity and cell viability.\n- If results show no change, consider that other autophagy receptors (NBR1, optineurin) may dominate the sequestration of NLRP3 agonists.\n\nThis framework converts the seed idea—that aggregation may represent a last‑ditch ordering effort—into a testable model where the functional outcome of aggregates hingers on the cell’s ability to clear them, directly addressing the inflammasome paradox highlighted in the critique.